[This Week's IPO] Demand Forecasting and Subscription Schedule for the Second Week of May

In the second week of May, Autocrypt will conduct its institutional demand forecasting. Immunoncia, BioBijou, and Dalba Global are preparing for their public subscription offerings.

<Demand Forecasting>

◆Autocrypt= Autocrypt is an autonomous driving security solutions company established in August 2019 through a spin-off from the domestic security firm Penta Security. Its main services include ▲vehicle and traffic infrastructure communication (V2X) security ▲in-vehicle system (IVS) security ▲WP.29 consulting (cybersecurity consulting specialized for WP.29).

The company is offering a total of 1.4 million new shares. The desired public offering price range is 18,700 to 22,000 KRW per share. Demand forecasting will be held from May 9 to May 15, followed by public subscription for general investors on May 21 and 22. The lead underwriter is Daishin Securities.

<Public Subscription>

◆Immunoncia= The final offering price has been set at the upper end of the desired range, at 3,600 KRW per share. A total of 2,205 institutional investors participated in the demand forecasting, resulting in a competition ratio of 897 to 1. Public subscription for general investors will take place on May 7 and 8, with listing scheduled for May 19. The lead underwriter is Korea Investment & Securities.

Founded in 2016, Immunoncia’s main pipeline includes the PD-L1 monoclonal antibody 'IMC-001' and the next-generation CD47 monoclonal antibody 'IMC-002.' The company is also actively developing follow-up pipelines to enter the bispecific antibody market.

◆BioBijou= The final offering price has been set at the top of the price band, at 9,100 KRW per share. A total of 2,466 institutional investors participated in the demand forecasting, resulting in a final competition ratio of 1,094.25 to 1. Public subscription for general investors will be held over two days, May 8 and 9, with listing on the KOSDAQ market scheduled for May 20. The lead underwriter is Daishin Securities.

Established in 2018, BioBijou develops, manufactures, and sells a variety of medical aesthetic products, including skin boosters and HA fillers. The company has built a business model that enables it to handle all processes?development, production, and sales?in-house, and has secured differentiated competitiveness at each stage of the value chain. Its major brands include ▲Candorub ▲Asenart ▲Corena.

◆Dalba Global= The total number of shares offered is 654,000, with the desired price band set at 54,500 to 66,300 KRW per share. The total offering amount is expected to be approximately 35.6 to 43.4 billion KRW. Institutional demand forecasting will be conducted through May 7, with public subscription for general investors from May 9 to 12. The lead underwriter is Mirae Asset Securities.

Dalba, known for its 'Flight Attendant Mist' First Spray Serum, is a premium vegan skincare brand that uses Italian white truffle as its main ingredient. Dalba has differentiated itself from existing beauty products through its innovative offerings. The company has developed a patented ingredient, Trufferol, which combines Italian white truffle?renowned for its antioxidant properties?with tocopherol, a component that enhances skin elasticity and moisture, in an optimal ratio.